These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3390998)

  • 1. Disposition and irreversible plasma protein binding of tolmetin in humans.
    Hyneck ML; Smith PC; Munafo A; McDonagh AF; Benet LZ
    Clin Pharmacol Ther; 1988 Jul; 44(1):107-14. PubMed ID: 3390998
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Irreversible binding of zomepirac to plasma protein in vitro and in vivo.
    Smith PC; McDonagh AF; Benet LZ
    J Clin Invest; 1986 Mar; 77(3):934-9. PubMed ID: 3949982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversible binding of tolmetin, zomepirac, and their glucuronide conjugates to human serum albumin and plasma.
    Ojingwa JC; Spahn-Langguth H; Benet LZ
    J Pharmacokinet Biopharm; 1994 Feb; 22(1):19-40. PubMed ID: 8027947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and irreversible binding of tolmetin and its glucuronic acid esters in the elderly.
    Munafo A; Hyneck ML; Benet LZ
    Pharmacology; 1993 Nov; 47(5):309-17. PubMed ID: 8265721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linear and nonlinear assessment of tolmetin pharmacokinetics.
    Ayres JW; Weidler DJ; Sakmar E; Wagner JG
    Res Commun Chem Pathol Pharmacol; 1977 Aug; 17(4):583-93. PubMed ID: 897347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption and excretion of tolemetin in man.
    Cressman WA; Wortham GF; Plostnieks J
    Clin Pharmacol Ther; 1976 Feb; 19(2):224-33. PubMed ID: 1261159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced covalent binding of tolmetin to proteins in humans after multiple dosing.
    Zia-Amirhosseini P; Ojingwa JC; Spahn-Langguth H; McDonagh AF; Benet LZ
    Clin Pharmacol Ther; 1994 Jan; 55(1):21-7. PubMed ID: 8299313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disposition of zomepirac sodium in man.
    O'Neill PJ; Yorgey KA; Renzi NL; Williams RL; Benet LZ
    J Clin Pharmacol; 1982 Oct; 22(10):470-6. PubMed ID: 7174855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irreversible binding of tolmetin glucuronic acid esters to albumin in vitro.
    Munafo A; McDonagh AF; Smith PC; Benet LZ
    Pharm Res; 1990 Jan; 7(1):21-7. PubMed ID: 2300531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-performance liquid chromatographic determination of tolmetin, tolmetin glucuronide and its isomeric conjugates in plasma and urine.
    Hyneck ML; Smith PC; Unseld E; Benet LZ
    J Chromatogr; 1987 Sep; 420(2):349-56. PubMed ID: 3693506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Absorption and excretion of tolmetin in arthritic patients.
    Grindel JM; Migdalof BH; Plostnieks J
    Clin Pharmacol Ther; 1979 Jul; 26(1):122-8. PubMed ID: 445955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of esterase inhibition on the disposition of zomepirac glucuronide and its covalent binding to plasma proteins in the guinea pig.
    Smith PC; McDonagh AF; Benet LZ
    J Pharmacol Exp Ther; 1990 Jan; 252(1):218-24. PubMed ID: 2299592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bile duct ligation promotes covalent drug-protein adduct formation in plasma but not in liver of rats given zomepirac.
    Wang M; Dickinson RG
    Life Sci; 2000 Dec; 68(5):525-37. PubMed ID: 11197750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of probenecid on the formation and elimination of acyl glucuronides: studies with zomepirac.
    Smith PC; Langendijk PN; Bosso JA; Benet LZ
    Clin Pharmacol Ther; 1985 Aug; 38(2):121-7. PubMed ID: 3874742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous determination of tolmetin and its metabolite in biological fluids by high-performance liquid chromatography.
    Desiraju RK; Sedberry DC; Ng KT
    J Chromatogr; 1982 Oct; 232(1):119-28. PubMed ID: 7142320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent binding of zomepirac glucuronide to proteins: evidence for a Schiff base mechanism.
    Smith PC; Benet LZ; McDonagh AF
    Drug Metab Dispos; 1990; 18(5):639-44. PubMed ID: 1981713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Irreversible binding of tolmetin to macromolecules via its glucuronide: binding to blood constituents, tissue homogenates and subcellular fractions in vitro.
    Ojingwa JC; Spahn-Langguth H; Benet LZ
    Xenobiotica; 1994 Jun; 24(6):495-506. PubMed ID: 7975715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for covalent binding of acyl glucuronides to serum albumin via an imine mechanism as revealed by tandem mass spectrometry.
    Ding A; Ojingwa JC; McDonagh AF; Burlingame AL; Benet LZ
    Proc Natl Acad Sci U S A; 1993 May; 90(9):3797-801. PubMed ID: 8483897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent intramolecular acyl migration of zomepirac glucuronide.
    Hasegawa J; Smith PC; Benet LZ
    Drug Metab Dispos; 1982; 10(5):469-73. PubMed ID: 6128195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pH on acyl migration and hydrolysis of tolmetin glucuronide.
    Hyneck ML; Munafo A; Benet LZ
    Drug Metab Dispos; 1988; 16(2):322-4. PubMed ID: 2898354
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.